INNIO N.V. Ordinary Shares vs McKesson Corporation — how do they compare? INNIO N.V. Ordinary Shares trades at $15.67 (market cap $12.38B), while McKesson Corporation trades at $997.66 (market cap $113.86B). The key difference: McKesson Corporation is far larger — about 9.2× INNIO N.V. Ordinary Shares's market cap, and McKesson Corporation pays a 0.39% dividend while INNIO N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and McKesson Corporation for 74 Days on average.
| INIO | MCK | |
|---|---|---|
Market Cap | $12.38B | $113.86B |
Volume | 6,733,708 | 767,917 |
Sector | Industrials | Health |
52-Week High | $41.13 | $995.69 |
52-Week Low | $16.50 | $725.17 |
Typical Hold Time | 0 Days | 74 Days |
Enterprise Value | $14.04B | $120.40B |
Dividend Yield | — | 0.39% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McKesson (MCK) trades at $961.88, up 0.64% today, near its 52-week high and above the consensus price target of $956.43. The stock shows strong technical momentum with bullish moving averages and recent earnings beats. Revenue grew to $359.05B in 2025, with net income of $3.30B, though margins remain thin. Positive sentiment is fueled by a key partnership extension with CVS Health through 2032 and reaffirmed guidance.
Outlook remains positive with analyst consensus strongly bullish (80.65% buy ratings), supported by oncology and specialty distribution growth. Risks include drug pricing pressure and policy uncertainty. The stock's current valuation at a P/E of 26.2 reflects growth expectations, but investors should monitor margin sustainability amid rising costs.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →